Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:600671's Days Inventory is ranked better than 55.23% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.655
vs SHSE:600671: 150.94
Inventory Turnover measures how fast the company turns over its inventory within a year.
Hangzhou TianMuShan Pharmaceutical Enterprise Co's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.73.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Hangzhou TianMuShan Pharmaceutical Enterprise Co's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.73.
Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Hangzhou TianMuShan Pharmaceutical Enterprise Co's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Hangzhou TianMuShan Pharmaceutical Enterprise Co's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Hangzhou TianMuShan Pharmaceutical Enterprise Co Days Inventory Related Terms
Hangzhou TianMuShan Pharmaceutical Enterprise Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou TianMuShan Pharmaceutical Enterprise Co Days Inventory Chart
Hangzhou TianMuShan Pharmaceutical Enterprise Co Annual Data
SHSE:600671 vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, Hangzhou TianMuShan Pharmaceutical Enterprise Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou TianMuShan Pharmaceutical Enterprise Co Days Inventory vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) has a Days Inventory of 125.25 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Hangzhou TianMuShan Pharmaceutical Enterprise Co and its competitors. This is 28% below median its historical median of 174.83. Over the past decade, Hangzhou TianMuShan Pharmaceutical Enterprise Co's Days Inventory has ranged from 103.53 to 264.89. According to the industry distribution chart, Hangzhou TianMuShan Pharmaceutical Enterprise Co ranks #411 out of 918 companies in the Drug Manufacturers industry, placing it in the top 44.8%.
Is Hangzhou TianMuShan Pharmaceutical Enterprise Co's Days Inventory too high?
Hangzhou TianMuShan Pharmaceutical Enterprise Co's current Days Inventory of 125.25 is 28% below median its 10-year median of 174.83. Over the past 10 years, this metric has ranged from a low of 103.53 to a high of 264.89. The Drug Manufacturers industry median Days Inventory is 164.66. Hangzhou TianMuShan Pharmaceutical Enterprise Co's value of 125.25 is 23.9% below this industry median. Based on the distribution chart, Hangzhou TianMuShan Pharmaceutical Enterprise Co ranks #411 out of 918 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Hangzhou TianMuShan Pharmaceutical Enterprise Co has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hangzhou TianMuShan Pharmaceutical Enterprise Co's Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Hangzhou TianMuShan Pharmaceutical Enterprise Co ranks #411 out of 918 companies for Days Inventory. This puts Hangzhou TianMuShan Pharmaceutical Enterprise Co in the upper half of its industry. The industry median Days Inventory is 164.66. Hangzhou TianMuShan Pharmaceutical Enterprise Co's value of 125.25 is 23.9% below this benchmark. Historically, Hangzhou TianMuShan Pharmaceutical Enterprise Co's own Days Inventory has ranged from 103.53 to 264.89 over the past decade. While the company's 10-year median is 174.83 vs. the industry median of 164.66, Hangzhou TianMuShan Pharmaceutical Enterprise Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.66, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hangzhou TianMuShan Pharmaceutical Enterprise Co's current Days Inventory of 125.25 is 23.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Hangzhou TianMuShan Pharmaceutical Enterprise Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hangzhou TianMuShan Pharmaceutical Enterprise Co's current Days Inventory is 125.25, which is 28% below median its own 10-year median of 174.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou TianMuShan Pharmaceutical Enterprise Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥15.01, compared to a current price of ¥21.90 — trading 45.9% above its estimated fair value. The current Days Inventory is 125.25, which is 28% below median its 10-year median of 174.83 and 23.9% below the Drug Manufacturers industry median of 164.66. Hangzhou TianMuShan Pharmaceutical Enterprise Co's overall GF Score™ is 52/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671), the current Days Inventory is 125.25 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) Overvalued in 2026?
Based on GuruFocus' analysis, Hangzhou TianMuShan Pharmaceutical Enterprise Co stock appears to be overvalued.
The current stock price of ¥21.90 is trading 45.9% above its estimated GF Value™ of ¥15.01.
GuruFocus considers Hangzhou TianMuShan Pharmaceutical Enterprise Co to be Significantly Overvalued.
Key valuation signals for SHSE:600671:
Days Inventory: 125.25 (28% below median its 10-year median of 174.83)
GF Value™: ¥15.01 vs. price of ¥21.90 (45.9% above fair value)
Industry Position: 23.9% below the Drug Manufacturers median (#411 of 918)
No single metric tells the full story. See the SHSE:600671 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is engaged in producing proprietary Chinese medicines, biopharmaceuticals, healthy foods, medical equipment, and other medicines in China.
52GF Score
Get the complete analysis for SHSE:600671
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600671 has been successfully added to your 
